ZA934970B - Enzyme inhibitors - Google Patents

Enzyme inhibitors

Info

Publication number
ZA934970B
ZA934970B ZA934970A ZA934970A ZA934970B ZA 934970 B ZA934970 B ZA 934970B ZA 934970 A ZA934970 A ZA 934970A ZA 934970 A ZA934970 A ZA 934970A ZA 934970 B ZA934970 B ZA 934970B
Authority
ZA
South Africa
Prior art keywords
enzyme inhibitors
inhibitors
enzyme
Prior art date
Application number
ZA934970A
Other languages
English (en)
Inventor
James Leroy Kelley
David Patrick Baccanari Sr
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA934970B publication Critical patent/ZA934970B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA934970A 1992-07-10 1993-07-09 Enzyme inhibitors ZA934970B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929214720A GB9214720D0 (en) 1992-07-10 1992-07-10 Enzyme inhibitors

Publications (1)

Publication Number Publication Date
ZA934970B true ZA934970B (en) 1995-01-09

Family

ID=10718537

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA934970A ZA934970B (en) 1992-07-10 1993-07-09 Enzyme inhibitors

Country Status (9)

Country Link
EP (1) EP0649413A1 (xx)
JP (1) JPH07508983A (xx)
AU (1) AU4511693A (xx)
CA (1) CA2139836A1 (xx)
GB (1) GB9214720D0 (xx)
IL (1) IL106290A0 (xx)
MX (1) MX9304152A (xx)
WO (1) WO1994001414A1 (xx)
ZA (1) ZA934970B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306123B1 (it) 1999-04-02 2001-05-30 Technopharma Sa Soluzione oftalmica viscosizzata con azione detergente sulle lenti acontatto.
AR039540A1 (es) 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
US7605286B2 (en) 2003-08-06 2009-10-20 Sumitomo Chemical Company, Limited Hydroxy-protecting reagent and method of protecting hydroxy with the same
BRPI0615046C1 (pt) 2005-08-22 2021-05-25 Melior Discovery Inc uso de um composto
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
RU2427373C1 (ru) 2010-11-08 2011-08-27 Виктор Вениаминович Тец Средство для индукции эндогенного интерферона
EP3609500A4 (en) 2017-04-10 2020-08-19 Melior Pharmaceuticals I, Inc. ADIPOCYTE TREATMENT

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613604A (en) * 1985-07-31 1986-09-23 Brown University Research Foundation Hydroxymethyl derivatives of 5-benzylacyclouridine and 5-benzoyloxybenzylacyclouridine and their use as potentiators for 5-fluoro-2'-deoxyuridine
JPS63290867A (ja) * 1987-05-22 1988-11-28 Sds Biotech Kk ウラシル系化合物及び殺菌剤
US5077280A (en) * 1988-04-12 1991-12-31 Brown University Research Foundation Treatment of viral infections
DE69126469T2 (de) * 1990-03-29 1998-01-29 Mitsubishi Chem Corp Pyrimidin-Nukleosid-Derivate und antivirale Mittel, die diese Derivate als aktiven Bestandteil enthalten
US5141943A (en) * 1990-04-12 1992-08-25 Brown University Research Foundation 5-benzyl barbiturate derivatives

Also Published As

Publication number Publication date
WO1994001414A1 (en) 1994-01-20
JPH07508983A (ja) 1995-10-05
IL106290A0 (en) 1993-11-15
EP0649413A1 (en) 1995-04-26
GB9214720D0 (en) 1992-08-19
AU4511693A (en) 1994-01-31
MX9304152A (es) 1994-04-29
CA2139836A1 (en) 1994-01-20

Similar Documents

Publication Publication Date Title
IL108075A0 (en) Enzyme inhibitors
ZA917096B (en) Enzyme inhibitors
AU5533094A (en) Enzyme inhibitors
HU9302080D0 (en) Amine-diole protease inhibitors
EP0835109A4 (en) PYRIDINONE-BASED THROMBIN INHIBITORS
PL321759A1 (en) Novel thrombosin inhibitors
HU9601508D0 (en) Dp-iv-serine protease inhibitors
HU9303093D0 (en) Enzyme systhems
IL123653A0 (en) Chemokine inhibitor
GB9315846D0 (en) Tumour inhibitors
GB9425701D0 (en) Enzyme inhibitors
HU9503783D0 (en) Squvalen syntetase inhibitors
GB9502985D0 (en) Enzyme inhibitors
GB9214720D0 (en) Enzyme inhibitors
ZA939480B (en) Enzyme inhibitor
GB9212261D0 (en) Enzyme cloning
GB9303051D0 (en) 17b-nmonosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-en-3-one testosterone-5-alpha reductase inhibitors
ZA949525B (en) Enzyme inhibitors
ZA938867B (en) Enzyme inhibitors
GB9007750D0 (en) Enzyme inhibitors
GB9319663D0 (en) Enzyme inhibitors
GB9324981D0 (en) Enzyme inhibitors
ZA924089B (en) Novel thrombin inhibitors
KR100195376B1 (en) Haloethyl-substituted steroid enzyme inhibitors
GB9500553D0 (en) Enzyme inhibitors